Cargando…

Selexipag treatment in patients with systemic sclerosis–associated pulmonary arterial hypertension in clinical practice, a case series

OBJECTIVE: To describe the efficacy and safety in all patients with systemic sclerosis–associated pulmonary arterial hypertension who started selexipag between 09-2016 and 06-2018 in two pulmonary arterial hypertension expert centers. METHODS: All patients with systemic sclerosis–associated pulmonar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemmers, Jacqueline MJ, Fretheim, Håvard, Knaapen, Hanneke KA, van den Hoogen, Frank HJ, van Haren-Willems, Jolanda HGM, Duijnhouwer, Anthony L, van Dijk, Arie P, van den Ende, Cornelia HM, Hoffmann-Vold, Anna-Maria, Vonk, Madelon C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922617/ https://www.ncbi.nlm.nih.gov/pubmed/35382522 http://dx.doi.org/10.1177/2397198320916082

Ejemplares similares

Nailfold capillaroscopy and candidate-biomarker levels in systemic sclerosis-associated pulmonary hypertension: A cross-sectional study
por: Lemmers, Jacqueline MJ, et al.
Publicado: (2023)

Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties
por: Lemmers, Jacqueline M.J., et al.
Publicado: (2022)

Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis
por: Kersten, Brigit E, et al.
Publicado: (2020)

Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis
por: Kersten, Brigit E, et al.
Publicado: (2020)

The outcome of pulmonary hypertension and its association with pulmonary artery dilatation
por: Duijnhouwer, A. L., et al.
Publicado: (2020)

Photoacoustic and high-frequency ultrasound imaging of systemic sclerosis patients
por: Daoudi, Khalid, et al.
Publicado: (2021)

Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial
por: van den Hombergh, Wieneke M. T., et al.
Publicado: (2018)

Unraveling SSc Pathophysiology; The Myofibroblast
por: van Caam, Arjan, et al.
Publicado: (2018)

What moves the rheumatologist? Unravelling decision making in the referral of systemic sclerosis patients to health professionals: a qualitative study
por: Stöcker, Juliane K, et al.
Publicado: (2018)

Room for improvement in non-pharmacological systemic sclerosis care? — a cross-sectional online survey of 650 patients
por: Stöcker, Juliane K., et al.
Publicado: (2020)

Opening the black box of non-pharmacological care in systemic sclerosis: a cross-sectional online survey of Dutch health professionals
por: Stöcker, Juliane K., et al.
Publicado: (2020)

Pulmonary hypertension in connective tissue diseases, new evidence and challenges
por: Vonk, Madelon C., et al.
Publicado: (2020)

Economic Evaluation of the Dr. Bart Application in Individuals With Knee and/or Hip Osteoarthritis
por: Pelle, Tim, et al.
Publicado: (2022)

Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology
por: Bhansing, Kavish J, et al.
Publicado: (2014)

Vitality and the course of limitations in activities in osteoarthritis of the hip or knee
por: van Dijk, Gabriella M, et al.
Publicado: (2011)

Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
por: van den Hombergh, W. M. T., et al.
Publicado: (2018)

Selexipag for pulmonary arterial hypertension
Publicado: (2021)

Development and evaluation of a tailored e-self-management intervention (dr. Bart app) for knee and/or hip osteoarthritis: study protocol
por: Pelle, Tim, et al.
Publicado: (2019)

Evidence and consensus-based recommendations for non-pharmacological treatment of fatigue, hand function loss, Raynaud’s phenomenon and digital ulcers in patients with systemic sclerosis
por: Stöcker, Juliane K, et al.
Publicado: (2021)

Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis
por: Zwikker, Hanneke E, et al.
Publicado: (2014)

Psychosocial predictors of non-adherence to chronic medication: systematic review of longitudinal studies
por: Zwikker, Hanneke E, et al.
Publicado: (2014)

Use and usability of the dr. Bart app and its relation with health care utilisation and clinical outcomes in people with knee and/or hip osteoarthritis
por: Pelle, Tim, et al.
Publicado: (2021)

Selexipag in the management of pulmonary arterial hypertension: an update
por: Coghlan, J Gerry, et al.
Publicado: (2019)

Selexipag for the treatment of chronic thromboembolic pulmonary hypertension
por: Ogo, Takeshi, et al.
Publicado: (2022)

Requirements for systemic sclerosis expert centres in the Netherlands: A Delphi consensus study
por: Spierings, Julia, et al.
Publicado: (2020)

Little Evidence for Usefulness of Biomarkers for Predicting Successful Dose Reduction or Discontinuation of a Biologic Agent in Rheumatoid Arthritis: A Systematic Review
por: Tweehuysen, Lieke, et al.
Publicado: (2017)

Differences in Aortopathy in Patients with a Bicuspid Aortic Valve with or without Aortic Coarctation
por: Duijnhouwer, Anthonie, et al.
Publicado: (2020)

Author Comment on: Álvarez B, Montero Á, Aramburu F, Calvo E, Ángel de la Casa M, Valero J, et al. Radiotherapy for ostheoarticular degenerative disorders: When nothing else works. Osteoarthritis and Cartilage Open. 2019:100016
por: van den Ende, C.H.M., et al.
Publicado: (2020)

The Dutch Lower Extremity Functional Scale was highly reliable, valid and responsive in individuals with hip/knee osteoarthritis: a validation study
por: Hoogeboom, Thomas J, et al.
Publicado: (2012)

Hemodynamic and clinical effects of selexipag in children with pulmonary hypertension
por: Rothman, Abraham, et al.
Publicado: (2020)

Impact of physician’ and pharmacy staff supporting activities in usual care on patients’ statin adherence
por: Huiskes, Victor Johan Bernard, et al.
Publicado: (2022)

What factors explain the number of physical therapy treatment sessions in patients referred with low back pain; a multilevel analysis
por: Swinkels, Ilse CS, et al.
Publicado: (2005)

Cross-Language Measurement Equivalence of the Center for Epidemiologic Studies Depression (CES-D) Scale in Systemic Sclerosis: A Comparison of Canadian and Dutch Patients
por: Kwakkenbos, Linda, et al.
Publicado: (2013)

CD4+CD45RA+ T-cells from early diffuse systemic sclerosis patients produce high levels of interleukin-17
por: van Bon, Lenny, et al.
Publicado: (2011)

Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy
por: Hardin, Elizabeth Ashley, et al.
Publicado: (2016)

Baseline history of patients using selexipag for pulmonary arterial hypertension
por: Highland, Kristin B., et al.
Publicado: (2019)

Use of selexipag in a teenage patient with pulmonary arterial hypertension
por: Bravo-Valenzuela, Nathalie Jeanne Magioli, et al.
Publicado: (2021)

Effect of quercetin on the pharmacokinetics of selexipag and its active metabolite in beagles
por: Luo, Shun-bin, et al.
Publicado: (2021)

Transitioning selexipag to oral treprostinil in patients with pulmonary artery hypertension
por: Arevalo, Carlo, et al.
Publicado: (2022)

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value
por: van Boekel, Martinus AM, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_76r32ncfb2clvpg9q2umd1lqoe